Mr. Speaker, let us talk about the facts. Canadians are worried that the Conservatives are giving their friends at the major pharmaceutical companies exclusive rights to data. Those are the facts. Manufacturers of generic drugs face long delays and added costs to get their products on the market. Is that not a double standard?
How will families, who are already struggling to pay for medications, be able to afford them under such conditions?